Literature DB >> 31092102

Existing and emerging applications for the neuromodulation of nerve activity through targeted delivery of electric stimuli.

Claire Ginn1, Bipin Patel1, Robert Walker2.   

Abstract

The effective treatment of many diseases requires the use of multiple treatment strategies among which neuromodulation is playing an increasingly important role. Neuromodulation devices that act to normalize or modulate nerve activity through the targeted delivery of electrical stimuli will be the focus of this review. These devices encompass deep brain stimulators, vagus nerve stimulators, spinal cord simulators and sacral nerve stimulators. Already neuromodulation has proven successful in the treatment of a broad range of conditions from Parkinson's disease to chronic pain and urinary incontinence. Many of these approaches seek to exploit the activities of the autonomic nervous system, which influences organ function through the release of neurotransmitters and associated signalling cascades. This review will outline existing and emerging applications for each of these neuromodulation devices, proposed mechanisms of action and clinical studies evaluating both their safety and therapeutic efficacy.

Entities:  

Keywords:  Neuromodulation; deep brain stimulation; sacral nerve stimulation; spinal cord stimulation; vagus nerve stimulation

Mesh:

Year:  2019        PMID: 31092102     DOI: 10.1080/00207454.2019.1609473

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  2 in total

Review 1.  Alternative therapies for dry eye disease.

Authors:  Rhiya Mittal; Sneh Patel; Anat Galor
Journal:  Curr Opin Ophthalmol       Date:  2021-07-01       Impact factor: 4.299

2.  Human intracranial recordings reveal distinct cortical activity patterns during invasive and non-invasive vagus nerve stimulation.

Authors:  William L Schuerman; Kirill V Nourski; Ariane E Rhone; Matthew A Howard; Edward F Chang; Matthew K Leonard
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.